In intestinal cancer, the loss of the AhR enhances carcinogenesis in mouse models and treatment of wild-type mice with AhR agonists protects against chemical-induced and genetic models of colon cancer [42,43,44,45,46,47]. Here, AHR is linked to colonic neoplasm.